160 related articles for article (PubMed ID: 8342118)
1. Measurement of the proliferative activity of three different sublines of the Dunning rat prostate tumor R3327.
Lohr F; Wenz F; Flentje M; Peschke P; Hahn EW
Strahlenther Onkol; 1993 Jul; 169(7):438-45. PubMed ID: 8342118
[TBL] [Abstract][Full Text] [Related]
2. Differential sensitivity of three sublines of the rat Dunning prostate tumor system R3327 to radiation and/or local tumor hyperthermia.
Peschke P; Hahn EW; Wenz F; Lohr F; Braunschweig F; Wolber G; Zuna I; Wannenmacher M
Radiat Res; 1998 Oct; 150(4):423-30. PubMed ID: 9768856
[TBL] [Abstract][Full Text] [Related]
3. [The relative biological effectiveness (RBE) of fast neutrons on the Dunning rat prostate carcinoma R3327-HI].
Wenz F; Lohr F; Peschke P; Wolber G; Höver KH; Hahn EW
Strahlenther Onkol; 1993 Jul; 169(7):412-7. PubMed ID: 8342114
[TBL] [Abstract][Full Text] [Related]
4. Flow cytometric analysis of R3327 rat prostate adenocarcinoma grown in vivo and in vitro.
Claflin AJ; Pollack A; Malinin T; Block NL; Irvin GL
J Natl Cancer Inst; 1982 Jul; 69(1):79-87. PubMed ID: 6954325
[TBL] [Abstract][Full Text] [Related]
5. Quiescence in R3327-G rat prostate tumors after androgen ablation.
Pollack A; Joon DL; Wu CS; Sikes C; Hasegawa M; Terry NH; White RA; Zagars GK; Meistrich ML
Cancer Res; 1997 Jun; 57(12):2493-500. PubMed ID: 9192831
[TBL] [Abstract][Full Text] [Related]
6. Influence of sampling time on assessment of potential doubling time.
Høyer M; Bentzen SM; Salling LN; Overgaard J
Cytometry; 1994 Jun; 16(2):144-51. PubMed ID: 7924683
[TBL] [Abstract][Full Text] [Related]
7. Flow cytometric measurement of proliferating cell nuclear antigen (PCNA) in solid tumors.
Wenz F; Lohr F; Flentje M
Strahlenther Onkol; 1994 Apr; 170(4):235-42. PubMed ID: 8165522
[TBL] [Abstract][Full Text] [Related]
8. Response of the R3327-AT1 Dunning prostate tumor to fast neutrons and cobalt-60.
Hahn EW; Wolber G; Bak M; Hoever KH; Gerlach L; Volm M; Lorenz WJ
Strahlenther Onkol; 1989 Apr; 165(4):283-5. PubMed ID: 2711333
[TBL] [Abstract][Full Text] [Related]
9. Cell proliferation kinetics in human tumor xenografts measured with iododeoxyuridine labeling and flow cytometry: a study of heterogeneity and a comparison between different methods of calculation and other proliferation measurements.
Perez LA; Dombkowski D; Efird J; Preffer F; Suit HD
Cancer Res; 1995 Jan; 55(2):392-8. PubMed ID: 7812972
[TBL] [Abstract][Full Text] [Related]
10. Tamoxifen-induced increase in the potential doubling time of MCF-7 xenografts as determined by bromodeoxyuridine labeling and flow cytometry.
Sarkaria JN; Gibson DF; Jordan VC; Fowler JF; Lindstrom MJ; Mulcahy RT
Cancer Res; 1993 Sep; 53(18):4413-7. PubMed ID: 8364937
[TBL] [Abstract][Full Text] [Related]
11. Measuring potential doubling times of murine tumors using flow cytometry.
Carlton JC; Terry NH; White RA
Cytometry; 1991; 12(7):645-50. PubMed ID: 1782833
[TBL] [Abstract][Full Text] [Related]
12. Effects of tamoxifen on potential doubling time of human breast cancer cell line determined by image cytometry of double fluorescent BrdU and DNA labeling.
Rostagno P; Moll JL; Birtwisle-Peyrottes I; Ettore F; Lagrange JL; Gioanni J; Caldani C
Anticancer Res; 1994; 14(5A):2025-32. PubMed ID: 7531416
[TBL] [Abstract][Full Text] [Related]
13. [Measurement of the kinetics of cell proliferation of cancer of the oropharynx in vivo by the incorporation of bromodeoxyuridine and flow cytometry].
Bourhis J; Wilson GD; Janot F; Chavaudra N; Leridant AM; Wibault P; Girinsky T; Luboinski B; Eschwege F; Malaise EP
Bull Cancer; 1991 Nov; 78(11):1045-51. PubMed ID: 1369550
[TBL] [Abstract][Full Text] [Related]
14. The effect of castration on tumor growth rate and cell kinetics in hormone sensitive and hormone insensitive rat prostatic adenocarcinomas.
Salling LN; Høyer M; Overgaard J
Scand J Urol Nephrol Suppl; 1995; 172():73-9. PubMed ID: 8578260
[TBL] [Abstract][Full Text] [Related]
15. [The in vivo use of bromodeoxyuridine for the study of cell kinetics in squamous tumors of the neck and head. Implications for the radiotherapist].
Corvò R; Giaretti W; Margarino G; Danova M; Vitale V
Radiol Med; 1991; 82(1-2):147-52. PubMed ID: 1896568
[TBL] [Abstract][Full Text] [Related]
16. S-phase arrest of nutrient deprived lung cancer cells.
Tinnemans MM; Lenders MH; ten Velde GP; Blijham GH; Ramaekers FC; Schutte B
Cytometry; 1995 Apr; 19(4):326-33. PubMed ID: 7796697
[TBL] [Abstract][Full Text] [Related]
17. Flow cytometric characterization of tumor subpopulations in three sublines of the Dunning R3327 rat prostate tumor model.
Glowa C; Peschke P; Karger CP; Hahn EW; Huber PE; Debus J; Ehemann V
Prostate; 2013 Nov; 73(15):1710-20. PubMed ID: 23853045
[TBL] [Abstract][Full Text] [Related]
18. Cell kinetics in human malignancies studied with in vivo administration of bromodeoxyuridine and flow cytometry.
Riccardi A; Danova M; Wilson G; Ucci G; Dörmer P; Mazzini G; Brugnatelli S; Girino M; McNally NJ; Ascari E
Cancer Res; 1988 Nov; 48(21):6238-45. PubMed ID: 3167869
[TBL] [Abstract][Full Text] [Related]
19. Estimation of the dividing fraction and potential doubling time of tumors using cytochalasin B.
Shibamoto Y; Streffer C
Cancer Res; 1991 Oct; 51(19):5134-8. PubMed ID: 1913638
[TBL] [Abstract][Full Text] [Related]
20. Cell proliferation of human leukemia and solid tumors studied with in vivo bromodeoxyuridine and flow cytometry.
Giordano M; Riccardi A; Danova M; Brugnatelli S; Mazzini G
Cancer Detect Prev; 1991; 15(5):391-6. PubMed ID: 1751950
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
